HomeClinical TopicsFDA approves new treatment for advanced soft tissue sarcoma

FDA approves new treatment for advanced soft tissue sarcoma

On Oct. 19, the Food and Drug Administration (FDA) approved Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...